{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:29:27Z","timestamp":1792373367236,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["311251\/2022-6"],"award-info":[{"award-number":["311251\/2022-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["402417\/2023-2"],"award-info":[{"award-number":["402417\/2023-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Minas Gerais State Foundation of Support to the Research","doi-asserted-by":"publisher","award":["APQ-04607-23"],"award-info":[{"award-number":["APQ-04607-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Minas Gerais State Foundation of Support to the Research","doi-asserted-by":"publisher","award":["APQ-02613-23"],"award-info":[{"award-number":["APQ-02613-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.rvsc.2025.105820","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T22:34:10Z","timestamp":1753569250000},"page":"105820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Potential immunoprophylactic use of a multi-epitope protein of CD4+ and CD8+ T cells against visceral leishmaniasis in Balb\/c mice"],"prefix":"10.1016","volume":"194","author":[{"given":"Scarleth Silva","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naianda Rezende","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"dos Reis Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Jos\u00e9 Lucas","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Tamietti","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Pagliara","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danniele Luciana","family":"Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilly Vit\u00f3ria Silva","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia Coral","family":"Galvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Paulino","family":"Luiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eduarda","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Andrez","family":"Machado-de-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Ravena Severino","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00edbia Mariana","family":"Eleut\u00e9rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Salles Moura","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Antonio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Mendes","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Costa","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rvsc.2025.105820_bb0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12917-021-02816-x","article-title":"Expression analysis of centrin gene in promastigote and amastigote forms of leishmania infantum iranian isolates: a promising target for live attenuated vaccine development against canine leishmaniasis","volume":"17","author":"Abbaszadeh Afshar","year":"2021","journal-title":"BMC Vet. Res."},{"issue":"9","key":"10.1016\/j.rvsc.2025.105820_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13090812","article-title":"Advances in Leishmania vaccines: current development and future prospects","volume":"13","author":"Ayala","year":"2024","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.rvsc.2025.105820_bb0015","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/infdis\/154.6.1003","article-title":"New perspectives on a subclinical form of visceral leishmaniasis","volume":"154","author":"Badaro","year":"1986","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.rvsc.2025.105820_bb0020","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cvsm.2022.06.012","article-title":"Leishmaniasis","volume":"52","author":"Baneth","year":"2022","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"8","key":"10.1016\/j.rvsc.2025.105820_bb0025","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.rvsc.2025.105820_bb0030","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.pt.2024.07.013","article-title":"The immunomicrotope of Leishmania control and persistence","volume":"40","author":"Bogdan","year":"2024","journal-title":"Trends Parasitol."},{"issue":"2","key":"10.1016\/j.rvsc.2025.105820_bb0035","article-title":"Chimeric vaccines designed by Immunoinformatics-activated Polyfunctional and memory T cells that trigger protection against experimental visceral Leishmaniasis","volume":"8","author":"Brito","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"21","key":"10.1016\/j.rvsc.2025.105820_bb0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/vr.141.21.539","article-title":"A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum","volume":"141","author":"Ciaramella","year":"1997","journal-title":"Vet. Rec."},{"issue":"7","key":"10.1016\/j.rvsc.2025.105820_bb0045","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.rvsc.2025.105820_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.rvsc.2025.105820_bb0055","article-title":"Control of canine visceral leishmaniasis by euthanasia: estimated effect based on a survey and mathematical modeling","volume":"36","author":"Costa","year":"2020","journal-title":"Cad. Saude Publica"},{"key":"10.1016\/j.rvsc.2025.105820_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106865","article-title":"Immunoproteomics approach for the discovery of antigens applied to the diagnosis of canine visceral leishmaniasis","volume":"241","author":"Costa","year":"2023","journal-title":"Acta Trop."},{"issue":"12","key":"10.1016\/j.rvsc.2025.105820_bb0065","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1007\/s00253-022-12033-7","article-title":"Development of an immunogen containing CD4(+)\/CD8(+) T-cell epitopes for the prophylaxis of tegumentary leishmaniasis","volume":"106","author":"de Andrade Ferraz","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.rvsc.2025.105820_bb0070","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s13071-016-1752-6","article-title":"Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec(R) and Leishmune(R) vaccines against visceral leishmaniasis","volume":"9","author":"de Mendonca","year":"2016","journal-title":"Parasit. Vectors"},{"issue":"5","key":"10.1016\/j.rvsc.2025.105820_bb0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.rvsc.2025.105820_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2017.11.001","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"323","author":"Dias","year":"2018","journal-title":"Cell. Immunol."},{"issue":"11","key":"10.1016\/j.rvsc.2025.105820_bb0085","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/CVI.00465-15","article-title":"Proteins selected in Leishmania (Viannia) braziliensis by an Immunoproteomic approach with potential Serodiagnosis applications for Tegumentary Leishmaniasis","volume":"22","author":"Duarte","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"issue":"4","key":"10.1016\/j.rvsc.2025.105820_bb0090","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1590\/0037-8682-0120-2016","article-title":"Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis","volume":"49","author":"Duarte","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.rvsc.2025.105820_bb0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molimm.2016.06.014","article-title":"A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection","volume":"76","author":"Duarte","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.rvsc.2025.105820_bb0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cellimm.2018.07.002","article-title":"Development of a new live attenuated Leishmania major p27 gene knockout: safety and immunogenicity evaluation in BALB\/c mice","volume":"332","author":"Elikaee","year":"2018","journal-title":"Cell. Immunol."},{"issue":"24","key":"10.1016\/j.rvsc.2025.105820_bb0105","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.vaccine.2019.04.068","article-title":"Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB\/c mice","volume":"37","author":"Elikaee","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2025.105820_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.106153","article-title":"Live attenuated Leishmania major p27 gene knockout as a novel vaccine candidate: a study on safety, protective immunity and efficacy against canine leishmaniasis caused by Leishmania infantum","volume":"225","author":"Elikaee","year":"2022","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.rvsc.2025.105820_bib337","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/jvi.55.3.836-839.1985","article-title":"Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide","volume":"55","author":"Emini","year":"1985","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.rvsc.2025.105820_bb0115","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pt.2004.08.009","article-title":"Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis","volume":"20","author":"Engwerda","year":"2004","journal-title":"Trends Parasitol."},{"issue":"46","key":"10.1016\/j.rvsc.2025.105820_bb0120","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.rvsc.2025.105820_bb0125","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.vaccine.2013.12.046","article-title":"Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis","volume":"32","author":"Fernandes","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2025.105820_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2025.108914","article-title":"Synthetic peptides derived from hypothetical proteins as potential antigens for the diagnosis of canine visceral leishmaniasis and tegumentary leishmaniasis","volume":"270","author":"Freire","year":"2025","journal-title":"Exp. Parasitol."},{"issue":"18","key":"10.1016\/j.rvsc.2025.105820_bb0135","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1007\/s00253-021-11518-1","article-title":"Development of a chimeric protein based on a proteomic approach for the serological diagnosis of human tegumentary leishmaniasis","volume":"105","author":"Garcia","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.rvsc.2025.105820_bb0140","series-title":"Protein Identification and Analysis Tools on the ExPASy Server","first-page":"571","article-title":"Bairoch a","author":"Gasteiger","year":"2005"},{"issue":"5","key":"10.1016\/j.rvsc.2025.105820_bb0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0738-081X(96)00040-5","article-title":"Vaccine for prophylaxis and immunotherapy, Brazil","volume":"14","author":"Genaro","year":"1996","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.rvsc.2025.105820_bb0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fcimb.2019.00427","article-title":"An overview of immunotherapeutic approaches against canine visceral Leishmaniasis: what has been tested on dogs and a new perspective on improving treatment efficacy","volume":"9","author":"Goncalves","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.rvsc.2025.105820_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185438","article-title":"Field trial of efficacy of the Leish-tec(R) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates","volume":"12","author":"Grimaldi","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rvsc.2025.105820_bb0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12639-012-0171-7","article-title":"Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis","volume":"37","author":"Kaur","year":"2013","journal-title":"J. Parasit. Dis."},{"issue":"3","key":"10.1016\/j.rvsc.2025.105820_bb0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00281-015-0489-1","article-title":"CD8+ T cell immune response against non-viral pathogens","volume":"37","author":"Khan","year":"2015","journal-title":"Semin. Immunopathol."},{"issue":"3","key":"10.1016\/j.rvsc.2025.105820_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin. Transl. Immunol."},{"issue":"7","key":"10.1016\/j.rvsc.2025.105820_bb0175","article-title":"A recombinant chimeric protein-based vaccine containing T-cell epitopes from amastigote proteins and combined with distinct adjuvants, induces immunogenicity and protection against Leishmania infantum infection","volume":"10","author":"Lage","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.rvsc.2025.105820_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1051\/parasite\/2017039","article-title":"Further evidence associating IgG1, but not IgG2, with susceptibility to canine visceral leishmaniasis caused by Leishmania (L.) infantum chagasi-infection","volume":"24","author":"Lima","year":"2017","journal-title":"Parasite"},{"issue":"2","key":"10.1016\/j.rvsc.2025.105820_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020142","article-title":"TLR agonists as vaccine adjuvants targeting cancer and infectious diseases","volume":"13","author":"Luchner","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.rvsc.2025.105820_bb0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-1-0716-1884-4_24","article-title":"In silico design of recombinant chimera T Cell peptide epitope vaccines for visceral leishmaniasis","volume":"2410","author":"Machado","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.rvsc.2025.105820_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002764","article-title":"Identification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasites","volume":"8","author":"Magalhaes","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.rvsc.2025.105820_bb0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2016.05.018","article-title":"PLGA nanoparticles modified with a TNFalpha mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation","volume":"105","author":"Margaroni","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.rvsc.2025.105820_bb0205","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2147\/IJN.S141069","article-title":"Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFalpha-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis","volume":"12","author":"Margaroni","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.rvsc.2025.105820_bb0210","article-title":"Immunoinformatics approach to design a multi-epitope Nanovaccine against Leishmania parasite: elicitation of cellular immune responses","volume":"11","author":"Margaroni","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.rvsc.2025.105820_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD4(+) and CD8(+) T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.rvsc.2025.105820_bb0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cellimm.2016.12.008","article-title":"A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection","volume":"313","author":"Martins","year":"2017","journal-title":"Cell. Immunol."},{"issue":"21","key":"10.1016\/j.rvsc.2025.105820_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126178","article-title":"CD4(+) and CD8(+) T-cell multi-epitope chimeric protein associated with an MPLA adjuvant induce protective efficacy and long-term immunological memory for the immunoprophylaxis of American Tegumentary Leishmaniasis","volume":"42","author":"Moura","year":"2024","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.rvsc.2025.105820_bb0230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.apjtm.2015.06.008","article-title":"Immunogenicity and efficacy of recombinant 78 kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis","volume":"8","author":"Nagill","year":"2015","journal-title":"Asian Pac J Trop Med"},{"issue":"20","key":"10.1016\/j.rvsc.2025.105820_bb0235","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.vaccine.2021.04.004","article-title":"A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB\/c mice","volume":"39","author":"Ostolin","year":"2021","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.rvsc.2025.105820_bb0240","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pt.2013.05.003","article-title":"The prevention of canine leishmaniasis and its impact on public health","volume":"29","author":"Otranto","year":"2013","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/j.rvsc.2025.105820_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/22.1.1","article-title":"Clinical spectrum of Leishmaniasis","volume":"22","author":"Pearson","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rvsc.2025.105820_bib338","first-page":"185","article-title":"Prediction of peptide-MHC binding using profiles. Methods in Molecular Biology (Clifton","volume":"409","author":"Reche","year":"2007","journal-title":"N.J.)"},{"issue":"12","key":"10.1016\/j.rvsc.2025.105820_bb0250","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.rvsc.2025.105820_bb0255","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.vaccine.2016.03.019","article-title":"Field randomized trial to evaluate the efficacy of the Leish-Tec(R) vaccine against canine visceral leishmaniasis in an endemic area of Brazil","volume":"34","author":"Regina-Silva","year":"2016","journal-title":"Vaccine"},{"issue":"1\u20133","key":"10.1016\/j.rvsc.2025.105820_bb0260","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetimm.2008.10.307","article-title":"Systemic and compartmentalized immune response in canine visceral leishmaniasis","volume":"128","author":"Reis","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.rvsc.2025.105820_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114306","article-title":"Development of a topical treatment for tegumentary leishmaniasis using 8-hydroxyquinoline","volume":"199","author":"Rezende Ribeiro","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.rvsc.2025.105820_bb0270","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molimm.2018.12.025","article-title":"Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection","volume":"106","author":"Ribeiro","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.rvsc.2025.105820_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112641","article-title":"Immunodiagnosis of human and canine visceral leishmaniasis using recombinant Leishmania infantum Prohibitin protein and a synthetic peptide containing its conformational B-cell epitope","volume":"474","author":"Rodrigues","year":"2019","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.rvsc.2025.105820_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000584","article-title":"Control of visceral leishmaniasis in latin america-a systematic review","volume":"4","author":"Romero","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.rvsc.2025.105820_bib336","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of Continuous B-cell Epitopes in an Antigen Using Recurrent Neural Network","volume":"(1),","author":"Saha","year":"2006","journal-title":"Proteins,65"},{"key":"10.1016\/j.rvsc.2025.105820_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2024.104826","article-title":"Leishmania vaccine development: a comprehensive review","volume":"399-400","author":"Saini","year":"2024","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.rvsc.2025.105820_bb0290","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pt.2019.10.006","article-title":"Leishmania infantum","volume":"36","author":"Serafim","year":"2020","journal-title":"Trends Parasitol."},{"issue":"4","key":"10.1016\/j.rvsc.2025.105820_bb0295","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Vet. Parasitol."},{"issue":"1\u20132","key":"10.1016\/j.rvsc.2025.105820_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.05.022","article-title":"Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis","volume":"165","author":"Solano-Gallego","year":"2009","journal-title":"Vet. Parasitol."},{"issue":"2","key":"10.1016\/j.rvsc.2025.105820_bb0305","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/prca.200780012","article-title":"Immunoproteomics: from biomarker discovery to diagnostic applications","volume":"2","author":"Tjalsma","year":"2008","journal-title":"Proteomics Clin. Appl."},{"issue":"1","key":"10.1016\/j.rvsc.2025.105820_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006082","article-title":"Canine visceral leishmaniasis: diagnosis and management of the reservoir living among us","volume":"12","author":"Travi","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.rvsc.2025.105820_bb0315","article-title":"Efficacy of an immunotherapy combining immunogenic chimeric protein plus adjuvant and amphotericin B against murine visceral Leishmaniasis","volume":"12","author":"Vale","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.rvsc.2025.105820_bb0320","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.prevetmed.2018.10.015","article-title":"Seroprevalence of canine Leishmania infantum infection in the Mediterranean region and identification of risk factors: the example of north-eastern and Pyrenean areas of Spain","volume":"162","author":"Velez","year":"2019","journal-title":"Prev. Vet. Med."},{"issue":"49","key":"10.1016\/j.rvsc.2025.105820_bb0325","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1016\/j.vaccine.2019.09.067","article-title":"Effect on cellular recruitment and the innate immune response by combining saponin, monophosphoryl lipid-a and incomplete Freund\u2019s adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine formulation","volume":"37","author":"Vitoriano-Souza","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2025.105820_bb0330","series-title":"World Helth Organization","volume":"2023","author":"WHO","year":"2023"},{"key":"10.1016\/j.rvsc.2025.105820_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2023.101984","article-title":"Live attenuated Leishmania infantum centrin deleted mutant (LiCen(\u2212\/\u2212)) as a novel vaccine candidate: a field study on safety, immunogenicity, and efficacy against canine leishmaniasis","volume":"97","author":"Zarei","year":"2023","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528825002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528825002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:44:16Z","timestamp":1777441456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528825002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":70,"alternative-id":["S0034528825002942"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2025.105820","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential immunoprophylactic use of a multi-epitope protein of CD4+ and CD8+ T cells against visceral leishmaniasis in Balb\/c mice","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2025.105820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105820"}}